Europe
Danish company Ambu plopped down $265M to acquire Germany-based Invendo Medical, a privately-held medtech company that develops single-use high definition endoscopy products.
Big pharmas are having a good year so far in terms of FDA approvals.
The former Biogen CEO is making waves at his new venture, Vir Biotechnology.
The drug developed by Nogra always seemed like a longshot, but Celgene management talked it up over the years as it advanced.
Finding a treatment for Sanfilippo Syndrome is a personal matter for the Lysogene team.
Here is how you can land a job at one of the biggest pharmaceuticals in the world.
The FDA based its decision on data from the COMBI-AD Phase III trial.
DBV’s share price crumbled over the weekend after its Phase III peanut allergy trial failed to show a statistically significant response against placebo.
ADC Therapeutics announced it had raised $200M through an oversubscribed private placement.
PRESS RELEASES